ALL
73
10
ED
45
-4
NKE
21
-2
OMC
55
-3
WFC
77
3
FE
52
-8
FCX
50
2
EXR
48
8
GOOGL
48
3
HAS
48
2
SIG
63
3
C
60
5
AMAT
42
2
LEG
31
2
CFG
62
2
BLK
66
3
ORLY
64
2
CTAS
39
3
ALLE
41
9
STX
52
3
ALL
73
10
ED
45
-4
NKE
21
-2
OMC
55
-3
WFC
77
3
FE
52
-8
FCX
50
2
EXR
48
8
GOOGL
48
3
HAS
48
2
SIG
63
3
C
60
5
AMAT
42
2
LEG
31
2
CFG
62
2
BLK
66
3
ORLY
64
2
CTAS
39
3
ALLE
41
9
STX
52
3
Financhill
Back

Alkermes PLC 10K Form

Sell
48

ALKS
Alkermes PLC

Last Price:
$34.80
Seasonality Move:
2.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-01 10Q ALKS/Alkermes PLC Quarterly
2023-10-25 10Q ALKS/Alkermes PLC Quarterly
2023-07-26 10Q ALKS/Alkermes PLC Quarterly
2023-04-26 10Q ALKS/Alkermes PLC Quarterly
2022-11-02 10Q ALKS/Alkermes PLC Quarterly
2022-07-27 10Q ALKS/Alkermes PLC Quarterly

Receive ALKS News And Ratings

See the #1 stock for the next 7 days that we like better than ALKS

ALKS Financial Statistics

Sales & Book Value

Annual Sales: $1.6B
Cash Flow: $180.6M
Price / Cash Flow: 14.52
Annual Sales: $9.03
Price / Book: 3.86

Profitability

EPS (TTM): 2.17000
Net Income (TTM): $367.1M
Gross Margin: $1.3B
Return on Equity: 28.24%
Return on Assets: 17.19%

Alkermes PLC Earnings Forecast

Key Alkermes PLC Financial Ratios

  • The Gross Profit Margin over the past 33 years for ALKS is 84.25%.
  • The Selling, General & Administrative Expenses for ALKS have been equal to 41.42% of Gross Profit Margin.
  • The Research & Development expenses have been 15.75% of Revenue.
  • The Interest Expense is 6.15% of Operating Income.
  • The Net Earning history of ALKS is 23.57% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 17 years.

Alkermes PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALKS
CUSIP: G01767
Website: alkermes.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.04
Quick Ratio: 2.45

Price-to-Earnings

Trailing P/E Ratio: 16.03
Forward P/E Ratio: 19.09

ALKS Technical Analysis vs Fundamental Analysis

Sell
48
Alkermes PLC (ALKS) is a Sell

Is Alkermes PLC a Buy or a Sell?

  • Alkermes PLC stock is rated a Sell
    The current Alkermes PLC [ALKS] share price is $34.79. The Score for ALKS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.